Evaluation of the Washington Intensive Supervision Program

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Pepperdine University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Pepperdine University
ClinicalTrials.gov Identifier:
NCT01343472
First received: April 26, 2011
Last updated: April 27, 2011
Last verified: April 2011
  Purpose

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).


Condition Intervention
Behavior
Drug Users
Behavioral: WISP supervision
Behavioral: Parole-as-usual

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Evaluation of the Washington Intensive Supervision Program

Further study details as provided by Pepperdine University:

Primary Outcome Measures:
  • Revocation rate [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Percentage of subjects in each condition who are revoked from parole and returned to prison


Secondary Outcome Measures:
  • % positive drug tests [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Percentage of random and scheduled drug tests that test positive for illicit drugs

  • Days incarcerated [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Total number of days incarcerated in jail or prison

  • % Missed appointments [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Percentage of parole appointments that are missed.

  • New arrests [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Number of new arrests.

  • Assessed risk [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Parolee risk assessment (high, medium, low)


Estimated Enrollment: 70
Study Start Date: January 2011
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: WISP supervision
Parolee supervised under WISP parole model.
Behavioral: WISP supervision
WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.
Other Name: HOPE supervision
Active Comparator: Parole-as-usual
Parolees supervised under Washington State's parole-as-usual
Behavioral: Parole-as-usual
Parolees are supervised under standard parole supervision practice in Washington State.
Other Name: PAU

Detailed Description:

This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inmates released by DOC to community corrections supervision
  • Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.
  • Have a parole supervision discharge date at least one year from the date of release from entry into WISP

Exclusion Criteria:

  • Level III Sex Offenders
  • Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).
  • Dangerously Mentally Ill (DMIO)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01343472

Contacts
Contact: Donta Harper 206-516-7709
Contact: Kimberli Dewing

Locations
United States, Washington
Seattle Community Justice Center Recruiting
Seattle, Washington, United States
Contact: Donta Harper    206-516-7709      
Contact: Linda Bonazza    206-516-7709      
Sponsors and Collaborators
Pepperdine University
Investigators
Principal Investigator: Angela Hawken, PHD Pepperdine University
  More Information

No publications provided

Responsible Party: Angela Hawken, Pepperdine University
ClinicalTrials.gov Identifier: NCT01343472     History of Changes
Other Study ID Numbers: SPP0311F08
Study First Received: April 26, 2011
Last Updated: April 27, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Pepperdine University:
Behavior
Drug users

ClinicalTrials.gov processed this record on August 19, 2014